Market news

GL's health business is accelerating premium growth, led by United American and Family Heritage, while adding diversification beyond life insurance.

Globe Life (GL) has drawn investor attention after recent share price swings, with the stock closing at $172.16. The move comes against a backdrop of mixed short term returns along with stronger multi year performance. Recent moves tell a mixed story. Globe Life’s share price has eased over the past week and quarter, yet the year to date share price return of 24.38% and five year total shareholder return of 97.35% point to momentum that has been built over a longer horizon. Scan Globe Life...

GL's health business gains momentum from strong premium growth, rate increases and expanding distribution, though medical inflation poses risks.

Globe Life (GL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

GL's premium growth, rising investment income and AI initiatives support earnings, while higher health claims remain a risk.

Globe Life Inc. recently increased its share repurchase authorization to US$2.50 billion, declared a US$0.33 quarterly dividend for October 2026, and announced the retirement of director David A. Rodriguez for personal reasons. These capital return decisions and board changes came soon after Q2 2026 results highlighted weaker sales trends and underwriting margins despite analyst optimism. Next, we’ll examine how the enlarged buyback authorization interacts with softer underwriting...

Globe Life (GL) is back in focus after its Q2 2026 earnings beat came alongside weaker sales trends and softer underwriting margins, a mix that has kept analyst sentiment cautiously optimistic. See our latest analysis for Globe Life. Globe Life's recent Q2 update and the expanded US$2.5b buyback authorization come after a strong run, with the stock's 90 day share price return of 16.74% and 1 year total shareholder return of 34.73% pointing to momentum that has built over several years. If...

Despite Globe Life’s outperformance relative to the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Accident and health insurers face medical-cost pressures, but stronger underwriting, technology adoption and demand for supplemental coverage support growth.

Globe Life Inc. (NYSE: GL) announced that its Board of Directors has declared a quarterly dividend of $0.33 per share on all of the outstanding common stock of the Company held of record as of close of business of the Company's transfer agent on October 5, 2026. The dividend will be paid on October 30, 2026.

Thomas Peter Kalmbach, Executive Vice President and Chief Financial Officer, on July 30, 2026, sold

Globe Life (GL) has an average rating of overweight and mean price target of $192.08, according to a

Detailed price information for Unumprovident Corp (UNM-N) from The Globe and Mail including charting and trades.

Globe Life Inc. recently reported its second-quarter 2026 results, with revenue of US$1,599.73 million and net income of US$287.75 million, and subsequently raised its full-year 2026 net operating earnings guidance to US$15.55–US$15.95 per diluted share, reflecting higher life underwriting margins, stronger health premiums and excess investment income. The updated outlook also factors in potential remeasurement gains of US$110 million to US$130 million from life and health assumption...

Detailed price information for Globe Life Inc (GL-N) from The Globe and Mail including charting and trades.

Detailed price information for Globe Life Inc (GL-N) from The Globe and Mail including charting and trades.

Detailed price information for Globe Life Inc (GL-N) from The Globe and Mail including charting and trades.

Detailed price information for Globe Life Inc (GL-N) from The Globe and Mail including charting and trades.

Globe Life (GL) has an average rating of overweight and mean price target of $192.75, according to a

Globe Life Inc (GL) reports a 20% increase in net income per share and a robust 7% growth in total premium revenue, despite challenges in life sales and investment portfolio.

Shares of insurance holding company Globe Life (NYSE:GL) fell 7.2% in the afternoon session after the company reported second-quarter earnings that met Wall Street's estimates but failed to excite investors. Revenue rose 6.7% year on year to $1.6 billion, roughly in line with estimates of $1.59 billion. Net premiums earned also matched expectations, coming in at $1.30 billion. On the bottom line, GAAP earnings per share of $3.65 narrowly beat expectations of $3.64. Despite the company meeting es

Globe Life (NYSE:GL) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire

GL misses Q2 earnings estimates but raises its 2026 outlook as premium growth, underwriting strength and investment income support results.

Moby summary of Globe Life Inc.'s Q2 2026 earnings call

Globe Life (NYSE:GL) reported higher second-quarter earnings and raised its full-year outlook, with executives pointing to favorable life underwriting trends, growth in health premiums and stronger excess investment income, while also addressing changes in online advertising and agent recruiting. F